AzTrials
AzTrials

Coronary Artery Bypass GraftingNCT04362033

Comparison of Dynamic Fluid Responsiveness by EIT and Transpulmonary Thermodilution in Postoperative of CABG Patients

A study testing Passive Leg Raising (PLR) and PEEP increment (PEEP) in people with Coronary Artery Bypass Grafting and Fluid Therapy, run by Ludhmila Abrahão Hajjar at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the stroke volume variation measured by both methods: transpulmonary thermodilution and electrical impedance tomography (EIT), during fluid responsiveness maneuvers and after fluid replacement in the immediate postoperative of coronary artery bypass grafting (CABG) patients. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Passive Leg Raising (PLR) and PEEP increment (PEEP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteBrazil
Study dates
22 Aug 2018to 22 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective CABG surgery
  • Age greater than 18 years old and less than 80 years old
  • Written inform consent

Who cannot join

  • Previous pulmonary disease or pulmonary hypertension
  • Previous renal replacement therapy
  • Left ventricular ejection fraction < 40%
  • Body mass index > 40 kg/m2
  • Atrial fibrillation
  • Presence of cardiac pacemaker or another implantable electronic device
Show all 9Show fewer
  • Bleeding associated to hemodynamic instability
  • Cardiac arrest or suspicion of neurological alteration
  • Hemodynamic instability (norepinephrine dose > 0.5 mcg/Kg/min)

Trial locations and contacts

1 site in 1 country.

Ludhmila A Hajjar, MD, PhD contact

11-26615000 ext. 5232

ludhmila@usp.br

Rafael M Ianotti, PT contact

11-995989126

rafael.ianotti@gmail.com

Brazil1 site, 1 recruiting
  • Heart Institute

    São Paulo, São Paulo, 05403000

    Ludhmila A Hajjar, MD, PhD, 11-26615232, ludhmila@usp.br

    Rafael Ianotti, PT, 11-995989126, rafael.ianotti@gmail.com

    Recruiting

Other trials in Brazil

About this study

Official title: Comparison of Dynamic Fluid Responsiveness Assessed by Electrical Impedance Tomography and Transpulmonary Thermodilution in Postoperative of Coronary Artery Bypass Grafting Patients

The purpose of this study is to evaluate the stroke volume variation measured by both methods: transpulmonary thermodilution and electrical impedance tomography (EIT), during fluid responsiveness maneuvers and after fluid replacement in the immediate postoperative of coronary artery bypass grafting (CABG) patients. Patients will be hemodinamically monitored with the VolumeView set in combination with EV1000 clinical platform and the display of valuable volumetric parameters (Edwards Lifesciences, California, USA). Simultaneoulsy, patients will be monitored with Enlight Electrical Impedance Tomography (Timpel, São Paulo, Brazil). Hemodynamic data will be assessed at baseline 1, one minute after the passive leg raising maneuver, after PEEP increment, and after 500 mL of Lactated Ringer's (bolus infusion). Blood gases sample will be assessed before and immediatly after the protocol.

Read the detailed description

In the ICU, immediately after CABG surgery, patients are submitted to mechanical ventilation (volume-controlled mode with tidal volume = 8mL/Kg of PBW, PEEP = 8cmH2O and FiO2 = 60%, respiratory rate to maintain PaCO2 = 35 - 45 mmHg); hemodynamically monitored with VolumeView set in combination with EV1000 clinical platform and the display of volumetric parameters (Edwards Lifesciences, California, USA). Electrical impedance tomography monitoring (Enlight, Timpel, São Paulo, Brazil) is performed with a pair of electrodes belt attached around the thorax at 4Th - 6Th intercostal space, and a flow sensor attached between the orotracheal tube and the Y connector from the ventilator.

Before initiate the protocol, patients are submitted to a bolus of usual care doses of sedation and muscular blockage (Fentanyl, Midazolam and Cisatracurium).

To assess fluid responsiveness patients will be submitted to two different maneuvers applied in a random way: Passive Leg Raising (PLR) ant PEEP increment (PEEP). And after these maneuvers patients will receive a bolus of 500 ml of Lactated Ringer's.

Measurements are performed one minute after each of these conditions:

  • Baseline: before both fluid responsiveness maneuvers, before and after Lactated Ringer infusion, patient is positioned in 450 semi-recumbent position;
  • PLR: Fluid responsiveness maneuver which patient is positioned from 450 semi-recumbent position to dorsal decubitus and the legs are raised at 450;
  • PEEP increment: Fluid responsiveness maneuver which consisted in increased the PEEP level 5 cmH2O above the mean airway pressure, patient is positioned in 450 semi-recumbent position
  • Infusion of 500 mL of Ringer's; 450 semi-recumbent position.

Transpulmonary Thermodilution assessment are performed by the injection of 3 cold salines in bolus - the injection volume varied from 10 - 20mL according to the patient's actual weight and EIT assessment are performed by 1 injection of 10 mL of hypertonic saline at 7.5 - 10% according to the patient's actual weight.

Being tested
Passive Leg Raising (PLR) and PEEP increment (PEEP)
Keywords
cardiac surgery, fluid responsiveness, transpulmonary thermodilution, electrical impedance tomography, passive leg raising, stroke volume variation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Passive Leg Raising (PLR) and PEEP increment (PEEP)Diagnostic test

    PLR: Fluid responsiveness maneuver which patient is positioned from 45 grade of semi-recumbent position to dorsal decubitus and the legs are raised at 45 grades; PEEP increment: Fluid responsiveness maneuver which consisted in increased the PEEP level 5 cmH2O above the mean airway pressure, patient is positioned in 45 grade of semi-recumbent position

Study groups in NCT04362033
Study groupRoleWhat they receive
PLR groupExperimentalPatients will be submitted to two different fluid responsiveness maneuvers in a cross over randomization: In PLR arm, patients will be submitted to the PLR maneuver (patient is positioned from 45 grade of semi-recumbent position to dorsal decubitus and the legs are raised at 45 grade) firstly, then PEEP increment maneuver. At the end, all patients will receive a bolus of 500mL of Lactate Ringer's
Receives: Diagnostic Test: Passive Leg Raising (PLR) and PEEP increment (PEEP)
PEEP groupExperimentalPatients will be submitted to two different fluid responsiveness maneuvers in a cross over randomization: In PEEP arm, patients will be submitted to the PEEP maneuver (consisted in increase the PEEP level 5 cmH2O above the mean airway pressure, patient is positioned in 45 grade of semi-recumbent position) firstly, then PLR maneuver. At the end, all patients will receive a bolus of 500mL of Lactate Ringer's
Receives: Diagnostic Test: Passive Leg Raising (PLR) and PEEP increment (PEEP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference between the variation of the stroke volume and impedance variation (mean difference in %)

    Mean difference between stroke volume variation and impedance variation during different fluid responsiveness maneuvers, baseline condition and after volume infusion assessed by transpulmonary thermodilution and pulse contour method for stroke volume using VolumeView system, and electrical impedance parameters measured by Electrical impedance tomography for impedance variation

    Measured: within 2 hours after patient admission in the ICU

  2. Correlation between the variation of the stroke volume and impedance variation

    Correlation test between the change (delta) of stroke volume and impedance variation during different fluid responsiveness maneuvers, baseline condition and after volume infusion assessed by transpulmonary thermodilution and pulse contour method for stroke volume using VolumeView system, and electrical impedance parameters measured by Electrical impedance tomography for impedance variation

    Measured: within 2 hours after patient admission in the ICU

Secondary outcomes (4)
  1. Agreement between stroke volume variation (delta) (mean difference in %, CI and limits of agreement)

    To evaluate the accuracy of the passive leg elevation (PLR) maneuver as a predictor of fluid responsiveness in the immediate postoperative of CABG, we will compare the variation in stroke volume before-and-after PLR and before-and-after the infusion of 500mL of Ringer lactate

    Measured: within 2 hours after patient admission in the ICU

  2. Agreement between stroke volume variation (SVV) delta during PLR maneuver and with the infusion of volume

    Comparison of Stroke volume variation (SVV) delta between passive leg raising and the infusion of 500mL of Ringer Lactate (mean difference in %, CI and limits of agreement)

    Measured: within 2 hours after patient admission in the ICU

  3. To evaluate the ability of increment of PEEP to predict fluid responsiveness

    Comparisson between change in percentage of the stroke volume measure by VolumeView, during fluid responsiveness tested by PEEP increasing, Passive leg raising, and the Gold standard, fluid infusion of 500mL of Ringer Lactate

    Measured: within 2 hours after patient admission in the ICU

  4. Safety of assessment stroke volume by EIT during fluid responsiveness Test (delta of Sodium, in mEq/mL)

    Mean difference in the plasmatic sodium measure before and after the protocol which include 6 injection of hypertonic saline

    Measured: within 2 hours after patient admission in the ICU

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2020
  2. Study start22 Aug 2018
  3. Primary completion22 Apr 2020 (estimated)
  4. Study completion22 Jun 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Model description
Patients will be submitted to two different fluid responsiveness maneuvers in a cross over randomization.
Masking
None (open label)
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04362033
Sponsor's protocol ID
90728718.7.0000.0068
Status last verified
Jan 2020
First submitted
31 Jan 2020
Last updated
24 Apr 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Braun F, Proenca M, Wendler A, Sola J, Lemay M, Thiran JP, Weiler N, Frerichs I, Becher T. Noninvasive measurement of stroke volume changes in critically ill patients by means of electrical impedance tomography. J Clin Monit Comput. 2020 Oct;34(5):903-911. doi: 10.1007/s10877-019-00402-z. Epub 2019 Oct 17.

    PubMed 31624996

Questions about this trial

What is this clinical trial studying?

A study testing Passive Leg Raising (PLR) and PEEP increment (PEEP) in people with Coronary Artery Bypass Grafting and Fluid Therapy, run by Ludhmila Abrahão Hajjar at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ludhmila A Hajjar, MD, PhD (11-26615000 ext. 5232, ludhmila@usp.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference between the variation of the stroke volume and impedance variation (mean difference in %) (time frame: within 2 hours after patient admission in the ICU). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04362033, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2020; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in